PORT WASHINGTON, New York—Drive DeVilbiss Healthcare, a respiratory care company, launched the “PulmO2” oxygen concentrator, a solution aiming to improve access to oxygen therapy in low- and middle-income countries. With over a million annual preventable deaths from hypoxemia in these regions, the PulmO2 intends to address a gap in health care.
The PulmO2's features, listed below, can be highly effective in resource-limited settings.